(3beta,16beta)-3,17-Dihydroxy-22-oxocholest-5-en-16-yl 2-O-acetyl-3-O-[2-O-(4-methoxybenzoyl)-beta-D-xylopyranosyl]-alpha-L-arabinopyranoside(CAS: 145075-81-6)

The compound is a sterol derivative with a molecular weight of approximately 1016 g/mol. It is poorly soluble in water but soluble in organic solvents like methanol and ethanol. The compound shows limited reactivity under normal conditions but can undergo hydrolysis under basic conditions. It crystallizes in a form suitable for X-ray analysis and exhibits spectroscopic properties typical of steroidal glycosides.

The compound can be synthesized through a series of enzymatic and chemical reactions involving the modification of cholic acid to form the desired steroidal structure. Catalytic hydrogenation, acetylation, and glycosylation steps are typically employed to achieve the final product with high selectivity and yield. Detailed reaction conditions and purification methods are described in recent literature.

This compound is primarily used in pharmaceutical industries for the development of new drugs. Its unique chemical structure makes it a potential candidate for use as a bioactive compound in therapeutic applications. While its use in polymers or semiconductors is speculative, it could potentially find applications in sensor technology due to its functional groups.

Proper personal protective equipment (PPE) such as gloves, goggles, and lab coats should be worn when handling this compound. It should be stored in a cool, dry place away from direct sunlight. In case of a spill, it should be handled in a fume hood using appropriate absorption materials. Safety data sheets (SDS) should be consulted for detailed spill and emergency handling procedures.